AZN vs KBR · P/E 28, $288.38B cap vs P/E 16, rev $3.91B
AstraZeneca PLC (AZN) versus KBR Inc (KBR) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
KBR Inc (KBR) is a engineering & construction company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported KBR revenue for 2026-07-03 was $3.91B. Net income was $198.0M. KBR currently screens at market cap $6.19B and trailing P/E 16.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. KBR currently screens at market cap $6.19B and trailing P/E 16.0.
Not investment advice. Open the AZN and KBR stock pages for the full models.
Not investment advice.